{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:22:24Z","timestamp":1792783344638,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Research Association for Lower Limb Artery Revascularization"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12928-025-01172-z","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T03:37:59Z","timestamp":1753501079000},"page":"881-889","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Long-term effects of statin and anticoagulant therapy on restenosis after drug-coated balloon angioplasty for femoropopliteal artery disease: results from the POPCORN registry"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0785-7835","authenticated-orcid":false,"given":"Yoshinori","family":"Tsubakimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuyoshi","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimitsu","family":"Soga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Tomoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daizo","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Tobita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amane","family":"Kozuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Fujihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"key":"1172_CR1","first-page":"124","volume":"92","author":"DN Feldman","year":"2018","unstructured":"Feldman DN, Armstrong EJ, Aronow HD, et al. SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions. Catheter Cardiovasc Interv. 2018;92:124\u201340.","journal-title":"Catheter Cardiovasc Interv"},{"key":"1172_CR2","doi-asserted-by":"publisher","first-page":"e005891","DOI":"10.1161\/CIRCINTERVENTIONS.117.005891","volume":"11","author":"PA Schneider","year":"2018","unstructured":"Schneider PA, Laird JR, Tepe G, et al. Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial. Circ Cardiovasc Interv. 2018;11:e005891.","journal-title":"Circ Cardiovasc Interv"},{"key":"1172_CR3","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jcin.2018.02.019","volume":"11","author":"A Micari","year":"2018","unstructured":"Micari A, Brodmann M, Keirse K, IN.PACT Global Study Investigators, et al. Drug-coated balloon treatment of femoropopliteal lesions for patients with intermittent claudication and ischemic rest pain: 2-year results from the INPACT Global Study. JACC Cardiovasc Interv. 2018;11:945\u201353.","journal-title":"JACC Cardiovasc Interv"},{"key":"1172_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJMoa1406235","volume":"373","author":"K Rosenfield","year":"2015","unstructured":"Rosenfield K, Jaff MR, White CJ, LEVANT 2 Investigators, et al. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med. 2015;373:145\u201353.","journal-title":"N Engl J Med"},{"key":"1172_CR5","first-page":"e025677","volume":"11","author":"Y Soga","year":"2022","unstructured":"Soga Y, Takahara M, Iida O, on behalf of the POPCORN investigators, et al. Vessel patency and associated factors of drug-coated balloon for femoropopliteal lesion. J Am Heart Assoc. 2022;11:e025677.","journal-title":"J Am Heart Assoc"},{"key":"1172_CR6","first-page":"CD000123","volume":"2007","author":"PP Aung","year":"2007","unstructured":"Aung PP, Maxwell HG, Jepson RG, et al. Lipid-lowering for peripheral arterial disease of the lower limb. Cochrane Database Syst Rev. 2007;2007:CD000123.","journal-title":"Cochrane Database Syst Rev"},{"key":"1172_CR7","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","volume":"366","author":"C Baigent","year":"2005","unstructured":"Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267\u201378.","journal-title":"Lancet"},{"key":"1172_CR8","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1161\/CIRCINTERVENTIONS.113.000274","volume":"6","author":"TR Vogel","year":"2013","unstructured":"Vogel TR, Dombrovskiy VY, Gali\u00f1anes EL, et al. Preoperative statins and limb salvage after lower extremity revascularization in the medicare population. Circ Cardiovasc Interv. 2013;6:694\u2013700.","journal-title":"Circ Cardiovasc Interv"},{"key":"1172_CR9","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1093\/eurheartj\/ehu080","volume":"35","author":"DJ Kumbhani","year":"2014","unstructured":"Kumbhani DJ, Steg PG, Cannon CP, et al. Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry. Eur Heart J. 2014;35:2864\u201372.","journal-title":"Eur Heart J"},{"key":"1172_CR10","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1055\/s-0040-1709711","volume":"120","author":"D Pastori","year":"2020","unstructured":"Pastori D, Farcomeni A, Milanese A, et al. Statins and major adverse limb events in patients with peripheral artery disease: a systematic review and meta-analysis. Thromb Haemost. 2020;120:866\u201375.","journal-title":"Thromb Haemost"},{"key":"1172_CR11","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1016\/j.jacc.2018.03.008","volume":"71","author":"SS Anand","year":"2018","unstructured":"Anand SS, Caron F, Eikelboom JW, et al. Major adverse limb events and mortality in patients with peripheral artery disease: the COMPASS trial. J Am Coll Cardiol. 2018;71:2306\u201315.","journal-title":"J Am Coll Cardiol"},{"key":"1172_CR12","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","volume":"382","author":"MP Bonaca","year":"2020","unstructured":"Bonaca MP, Bauersachs RM, Anand SS, et al. Rivaroxaban in peripheral artery disease after revascularization. N Engl J Med. 2020;382:1994\u20132004.","journal-title":"N Engl J Med"},{"key":"1172_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S1051-0443(91)72275-6","volume":"2","author":"RB Rutherford","year":"1991","unstructured":"Rutherford RB, Becker GJ. Standards for evaluating and reporting the results of surgical and percutaneous therapy for peripheral arterial disease. J Vasc Interv Radiol. 1991;2:169\u201374.","journal-title":"J Vasc Interv Radiol"},{"key":"1172_CR14","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jacc.2014.12.036","volume":"65","author":"MR Patel","year":"2015","unstructured":"Patel MR, Conte MS, Cutlip DE, et al. Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from peripheral academic research consortium (PARC). J Am Coll Cardiol. 2015;65:931\u201341.","journal-title":"J Am Coll Cardiol"},{"key":"1172_CR15","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","volume":"45","author":"L Mazzolai","year":"2024","unstructured":"Mazzolai L, Teixido-Tura G, Lanzi S, et al. 2024 ESC guidelines for the management of peripheral arterial and aortic diseases. Eur Heart J. 2024;45:3538\u2013700.","journal-title":"Eur Heart J"},{"key":"1172_CR16","doi-asserted-by":"publisher","first-page":"e1313","DOI":"10.1161\/CIR.0000000000001251","volume":"149","author":"HL Gornik","year":"2024","unstructured":"Gornik HL, Aronow HD, Goodney PP, et al. 2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease. Circulation. 2024;149:e1313\u2013410.","journal-title":"Circulation"},{"key":"1172_CR17","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jvs.2006.12.054","volume":"45","author":"Heart Protection Study Collaborative Group","year":"2007","unstructured":"Heart Protection Study Collaborative Group. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. 2007;45:645\u201354.","journal-title":"J Vasc Surg"},{"key":"1172_CR18","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1024\/0301-1526\/a000969","volume":"50","author":"JJF Belch","year":"2021","unstructured":"Belch JJF, Brodmann M, Baumgartner I, et al. Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease. Vasa. 2021;50:401\u201311.","journal-title":"Vasa"},{"key":"1172_CR19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ejvs.2009.06.002","volume":"38","author":"AH Momsen","year":"2009","unstructured":"Momsen AH, Jensen MB, Norager CB, et al. Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies. Eur J Vasc Endovasc Surg. 2009;38:463\u201374.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"1172_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11096-022-01513-5","volume":"45","author":"SK Braun","year":"2023","unstructured":"Braun SK, Jorge DW, Bortolanza G, et al. Effects of statin use on primary patency, mortality, and limb loss in patients undergoing lower-limb arterial angioplasty: a systematic review and meta-analysis. Int J Clin Pharm. 2023;45:17\u201325.","journal-title":"Int J Clin Pharm"},{"key":"1172_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s42155-023-00390-x","volume":"10","author":"M Fujihara","year":"2023","unstructured":"Fujihara M, Takahara M, Soga Y, et al. Application of first-generation high- and low-dose drug-coated balloons to the femoropopliteal artery disease: a sub-analysis of the POPCORN registry. CVIR Endovasc. 2023;10:41.","journal-title":"CVIR Endovasc"},{"key":"1172_CR22","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jcin.2023.12.028","volume":"17","author":"T Toyoshima","year":"2024","unstructured":"Toyoshima T, Takahara M, Iida O, POPCORN Investigators, et al. Intraluminal vs subintimal drug-coated balloon angioplasty for the treatment of femoropopliteal chronic total occlusions. JACC Cardiovasc Interv. 2024;17:608\u201318.","journal-title":"JACC Cardiovasc Interv"},{"key":"1172_CR23","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1177\/1526602820948240","volume":"27","author":"Y Soga","year":"2020","unstructured":"Soga Y, Iida O, Urasawa K, MDT-2113 SFA Japan Investigators, et al. Three-year results of the IN.PACT SFA Japan trial comparing drug-coated balloons with percutaneous transluminal angioplasty. J Endovasc Ther. 2020;27:946\u201355.","journal-title":"J Endovasc Ther"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-025-01172-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12928-025-01172-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-025-01172-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T16:39:39Z","timestamp":1757695179000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12928-025-01172-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1172"],"URL":"https:\/\/doi.org\/10.1007\/s12928-025-01172-z","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"value":"1868-4300","type":"print"},{"value":"1868-4297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"24 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Drs Soga Y, Iida O and Fujihara M received honoraria from BARD Japan and Medtronic Japan. The remaining author(s) have no disclosures to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with institutional guidelines and the Declaration of Helsinki, and received approval from the Institutional Review Board (IRB) of Kokura Memorial Hospital, which served as the central IRB. The approval was granted on July 23, 2018, and was subsequently accepted by the IRBs of all participating institutions (Ref.18072351).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}